image
Kura Oncology, Inc. KURA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 15.92
-3.46 %
$ 1.24 B
Market Cap
-6.77
P/E
BALANCE SHEET
449 M ASSETS
-1.62%
Growth Rates
1Year -1.62%
3Years -11.48%
5Years 19.74%
7Years 30.45%
10Years 194.76%
51.7 M LIABILITIES
43.39%
Growth Rates
1Year 43.39%
3Years 12.48%
5Years 19.28%
7Years 21.86%
10Years 81.52%
397 M EQUITY
169.84%
Growth Rates
1Year 169.84%
3Years 49.08%
5Years 36.00%
7Years 32.01%
10Years 124.19%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Kura Oncology, Inc.
image
Current Assets 432 M
Cash & Short-Term Investments 424 M
Receivables 0
Other Current Assets 8.52 M
Non-Current Assets 16.5 M
Long-Term Investments 0
PP&E 8.85 M
Other Non-Current Assets 7.6 M
Current Liabilities 35.3 M
Accounts Payable 2.3 M
Short-Term Debt 3.01 M
Other Current Liabilities 30 M
Non-Current Liabilities 16.4 M
Long-Term Debt 15.7 M
Other Non-Current Liabilities 705 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008
ASSETS
Cash & Cash Equivalents 37.3 51.8 90.7 325.5 26.1 16.1 11.4 9.7 15.4 1.1 6.57 K 4.8 K 4.22 K 26.9 K 11.1 K 7.51 K
Short Term Investments 386.6 386.2 427.3 307.8 210.8 162.9 81.7 58.1 70.3 0 0 0 0 0 0 0
Receivables 0 0 0 0 30 K 0.2 0.2 0.3 0.4 30 K 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 8.5 8.4 2.9 7.9 5.4 4.0 2.6 1.4 1.4 42 K 0 3.5 K 2.5 K 0 0 0
Total Current Assets 432.5 446.4 522.3 637.3 239.6 181.2 94.6 68.8 86.9 1.2 6.57 K 8.3 K 6.72 K 26.9 K 11.1 K 7.51 K
PP&E 8.9 6.4 8.2 8.4 44 K 0 10 K 40 K 71 K 27 K 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0.2 0.2 0.2 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 7.6 3.3 3.3 1.4 2.3 1.2 1.2 1.0 0.3 0.2 2.5 K 0 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 3.5 K 2.5 K 2.5 K 1.88 K 0
Total Assets 448.9 456.3 534.1 647.2 242.0 182.4 95.9 69.8 87.3 1.4 9.07 K 8.3 K 6.72 K 29.4 K 13 K 7.51 K
LIABILITIES
Accounts Payable 2.3 1.5 3.2 2.8 3.5 3.9 1.2 0.6 0.9 0.2 350 1.85 K 2.93 K 0 0 0
Short Term Debt 3.0 4.6 2.3 5.1 0.5 0 1.5 0 0 2.0 0.1 85 K 60 K 60 K 25 K 0
Other Current Liabilities 30.0 17.9 17.0 18.2 11.5 9.7 7.3 4.8 4.1 0.8 0 0 0 0 0 0
Total Current Liabilities 35.3 24.1 22.5 26.0 15.6 13.6 10.0 5.5 5.1 3.0 0.1 0.1 74.8 K 60 K 25 K 0
Long Term Debt 15.7 11.7 4.6 9.9 7.2 7.5 5.6 7.3 0 0.5 0.1 85 K 60 K 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0.7 0.3 0.4 0.4 0.4 0.3 0.4 0.2 0.1 1.3 87.3 K 68.2 K 48.2 K 10.4 K 6.61 K 0
Total Liabilities 51.7 36.0 27.4 36.3 23.2 21.4 16.0 12.9 5.2 4.8 0.1 0.1 74.8 K 70.4 K 31.6 K 0
EQUITY
Common Stock 7 K 7 K 7 K 7 K 5 K 4 K 3 K 2 K 2 K 50 K 500 500 500 500 500 500
Retained Earnings (721.4) (568.8) (433.0) (302.5) (212.9) (149.7) (89.3) (53.9) (26.3) (3.7) (0.2) (0.1) (0.1) 91 K 68.6 K 48.6 K
Other Accumulative Comprehensive Income/Loss (1.3) (8.0) (1.8) 46 K 0.3 (0.1) 49 K 18 K 87 K 1 K 0 0 0 0 0 0
Total Equity 397.3 (568.8) (433.0) (302.5) (212.9) (149.7) 79.9 56.9 82.1 (3.4) (0.1) 95.3 K 68 K 41 K 18.6 K 1.4 K
Total Liabilities and Equity 448.9 (532.8) (405.5) (266.2) (189.7) (128.3) 95.9 69.8 87.3 1.4 9.07 K 8.3 K 6.72 K 29.4 K 13 K 7.51 K
SHARES OUTSTANDING
Common Shares Outstanding 73.2 67.0 66.4 53.1 41.9 35.2 23.2 18.7 9.9 0.1 5.0 5.0 5.0 5.0 5.0 0